AzTrials
AzTrials

Lumbar Disc HerniationLomboDNNCT06763224

Prevalence of Neuropathic Pain After Non-instrumented Lumbar Spinal Surgery

An observational study of Lumbar Disc Herniation and Lumbar Spinal Stenosis, run by Centre Hospitalier de Colmar at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic neuropathic pain following lumbar spine surgery is often under-diagnosed and difficult to relieve. It can persist long after the operation, sometimes for months or even years, and has a major impact on the quality of life of patients who suffer from it. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Questionnaire and Physical Exam
How many people
39 participants
Where
1 siteFrance
Study dates
1 Jul 2024to 5 Sep 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Primary care clinic

Who may be able to join

  • Patients admitted for scheduled primary lumbar spine surgery without pedicle osteosynthesis or interbody cage.
  • Pathology concerned by programmed surgery: herniated disc or lumbar spinal stenosis, uncomplicated by motor or sphincter deficits.
  • Delay between 1st painful symptoms and surgery > 48h.
  • Non-inclusion criteria:
  • Surgery scheduled within 48 hours of onset of symptoms.
  • Presence of cauda equina syndrome
Show all 12Show fewer
  • Presence of motor-radicular deficit
  • Patients with neurological pathology prior to surgery
  • Major cognitive or sensory disorders preventing completion of the self-questionnaire
  • Patients under guardianship
  • Patients not covered by French social security.
  • Patients who develop an identified neurological pathology after surgery, regardless of the initial surgery (e.g. multiple sclerosis, spinal cord injury, etc.).

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpitaux Civils de Colmar

    Colmar, 68024

Other trials in France

About this study

Chronic neuropathic pain following lumbar spine surgery is often under-diagnosed and difficult to relieve. It can persist long after the operation, sometimes for months or even years, and has a major impact on the quality of life of patients who suffer from it. However, the scientific literature on the subject remains relatively poor, as evidenced by the absence of scientific studies on the prevalence of neuropathic pain after lumbar spinal surgery, whether instrumented or not.

The main aim of this study is to determine whether lumbar spine surgery has an impact on the prevalence of neuropathic pain. Participants will be followed up and complete a quality-of-life questionnaire for one year after surgery.

Being tested
Questionnaire and Physical Exam
Keywords
Neuropathic pain, Lumbar spinal surgery
Medical subject headings
Intervertebral Disc Displacement, Spinal Stenosis, Neuralgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaire and Physical ExamOther

    The neuropathic pain measured with the Neuropathic pain DN4 Questionnaire (Echelle de la Douleur Neuropathique en 4 questions - Neuropathic Pain Scale in 4 questions) The global pain measured with Visual Analogue Scale (VAS) The patient's permanent functional disability measured with the Oswestry disability index (ODI) The quality of life measured with the questionnaire EuroQol-5 Dimension (EQ-5D-5L)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of the proportion of patients with neuropathic pain between the day before surgery and 12 months after surgery.

    Comparison of the proportion of patients with a score ≥ 4 measured with the DN4 questionnaire one day before surgery and 12 months after surgery. The DN4 questionnaire (4-question neuropathic pain scale) is a diagnostic tool used to identify and assess neuropathic pain. The questionnaire aims to measure the presence of symptoms and signs commonly associated with neuropathic pain.

    The questionnaire comprises 10 items:

    • 7 items relate to the patient's description of his or her pain (burning, painful cold, electric shocks, tingling, numbness, itching).
    • 3 items are based on the clinician's sensory examination, focusing on touch and pinprick hypoesthesia, as well as brush-induced allodynia.

    The DN4 is scored out of 10 points. A score of 4 or more suggests the presence of neuropathic pain.

    Measured: The day before surgery and 12 months after surgery

Secondary outcomes (4)
  1. Evolution of post-operative neuropathic pain

    Proportion of patients with a DN4 score ≥ 4 at 1, 3 and 6 months post-operatively.

    The DN4 questionnaire (4-question neuropathic pain scale) is a diagnostic tool used to identify and assess neuropathic pain. The questionnaire aims to measure the presence of symptoms and signs commonly associated with neuropathic pain.

    The questionnaire comprises 10 items:

    • 7 items relate to the patient's description of his or her pain (burning, painful cold, electric shocks, tingling, numbness, itching).
    • 3 items are based on the clinician's sensory examination, focusing on touch and pinprick hypoesthesia, as well as brush-induced allodynia.

    Measured: At 1, 3 and 6 months after surgery

  2. Evolution of overall pain

    Global pain is measured using the Visual Analog Scale (VAS). The VAS is one of a number of pain assessment scales. Using a ruler, the score is determined by measuring the distance in mm on a 10 cm line between the "no pain" reference point and the patient's mark, giving a range of scores from 0 to 100. A higher score indicates greater pain intensity.

    Measured: The day before surgery and at 1, 3, 6 and 12 months after surgery

  3. Evolution of functionality and disability of patients

    The Oswestry Disability Index (ODI) is used to measure a patient's permanent functional disability. The ODI consists of 10 questions, scored from 0 to 5 (minimum to maximum). The total points for each section are added together, divided by the total possible points for all completed sections, and multiplied by 100 to create a disability percentage from 0 to 100%. A high percentage indicates significant disability.

    Measured: The day before surgery and at 1, 3, 6 and 12 months after surgery

  4. Evolution of quality of life measured with EQ-5D-5L

    The EuroQoL-5D-5L (EQ-5D-5L) self-administered questionnaire comprises 2 pages: one page with the 5-dimensional questionnaire EQ-5D and the visual analog quality-of-life scale EQ VAS. The EQ-5D explores the following 5 dimensions: mobility, personal care, usual activities, pain/discomfort and anxiety/depression. Each dimension has five levels: no problems, mild problems, moderate problems, severe problems and extreme problems. Patients are asked to indicate their state of health by ticking the box corresponding to the most appropriate statement in each of the five dimensions. The level chosen for each dimension corresponds to 1 number from 1 to 5 (1 = no problems, 5 = extreme problems).

    The VAS EQ records the patient's self-assessment of health status on a vertical visual analogue scale, the ends of which are entitled "The best health you can imagine" and "The worst health you can imagine". The VAS can be used as a quantitative measure of health status.

    Measured: The day before surgery and at 1, 3, 6 and 12 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2025
  2. Study start1 Jul 2024
  3. Primary completion5 Sep 2025
  4. Study completion5 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
39 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06763224
Sponsor's protocol ID
HCC-007
Other IDs
2024-A00923-44
Acronym
LomboDN
Status last verified
Feb 2026
First submitted
2 Jan 2025
Last updated
6 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Lumbar Disc Herniation and Lumbar Spinal Stenosis, run by Centre Hospitalier de Colmar at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of the proportion of patients with neuropathic pain between the day before surgery and 12 months after surgery. (time frame: The day before surgery and 12 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in